The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMI

BACKGROUND: Erythropoietin (Epo) has been shown to improve myocardial function in models of experimental myocardial infarction, but has also been associated with a rise in thromboembolic events. Thus, the aim of this study was to investigate the influence of Epo on platelet activation and coagulatio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Demetz, Gabriele, Laux, Magdalena, Scherhag, Armin, Hoekstra, Tiny, Suttorp, Marit M, Dekker, Friedo, Roest, Mark, Marcus-Kalish, Mira, Mittelman, Moshe, Ott, Ilka
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Original Clinical Investigation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4165375/
https://ncbi.nlm.nih.gov/pubmed/25228850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-9560-12-18
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak